Home | Introduction | Site Map | Success Stories | Research | Products | FAQ | Contact Us | WWC Audio |

 

 • Introduction
 •
Important Warning  
 •
About Vitamin B17
 •
Vitamin B17 as Preventative
 •
Metabolic Therapy in Cancer
 • B17 In Metabolic Therapy
 •
Laetrile and Cyanide
 •
Graphic on Action of B17
 •
Frequently Asked Questions
 •
B17 Therapy Components
 •
Accessory Supplements
 •
B17 Therapy Overview
 •
Therapies and Protocols
 •
What is in B17 Therapy?
 •
Maintenance Dosages
 •
Accessory Therapies
 •
Positive Thinking
 •
Implementing Changes
 •
Behaviour of Tumours
 •
Criteria For Evaluation
 •
B17 - Sickle Cell Anaemia
 •
Fluoridation-linked cancer
 •
Contacts 
 •
In God We Trust
 •
References

•  More Studies, Research








 

 


 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

CENTRAL NERVOUS SYSTEM
Case Histories Include Cancer of the Brain

Complete surgical removal of gliomas (brain cancer) is usually not possible(1). Four out of every five patients with cancer of the brain who do not use Laetrile but choose surgery and radiation instead will be dead within two years(2). The following Laetrile case histories should be read with these facts in mind.

*(1).Clinical Oncology for Medical Students and Physicians, op. cit., p. 262.

(2). Ibid, p. 270.

C165GX: Brain Tumor Astrocytoma, Grade II

This woman was thirty-two years old when her symptoms began. She had a six-month history of headaches prior to being hospitalized on May 7, 1975. She had also had several episodes of vomiting.

The admission examination stated in part:

Examination demonstrated bilateral papilledema (swelling at the back of both eyes]. A cerebral angiography [X-rays showing blood vessels in the brain] demonstrated an avascular mass [a tumor] in the left temporal parietal region [above the ear].
 
 

The dangers of brain surgery were explained to the patient and to her parents. They decided to proceed.

The surgery report dated May 10, 1975, stated in part:

The tumor measured approximately 8 cm. [about 3 inches] in its greatest dimension. . . .

While waiting for the frozen section report an attempt was made to circumvent the tumor

from the surrounding normal appearing brain tissue. . . . It soon became evident that this tumor had no real demarcation from the brain tissue from which it arose. . . .

Once it became clear that this tumor arose from the brain itself, no further attempt was made to circumvent this tumor mass. . . . Removal of the tumor by suctioning was continued until "normal appearing" white matter was encountered.

The operation was described as a "Left temporal parietal craniotomy with incomplete excision of astrocytoma, low grade."

Pathology diagnosis was ''Fibrillary Astrocytoma

Microcyst Formation (Grade II)."

Surgery was followed by twenty-seven radiation treatments, which the patient tolerated fairly well. These were begun on May 21, 1975.

According to Joseph McDonald, M.D., and Lowell Lapham, M.D., "Most glioblastoma [astrocytoma] patients recur and die within the first year(1)."

*(1).Clinical Oncology for Medical Students and Physicians, op. cit., p. 270

In this woman’s case, she was having recurrence of symptoms two months following surgery and radiation. The left side of her face had become swollen, and headaches and nausea had returned.

No attempt was made at this point to determine whether the tumor was recurring or radionecrosis was causing the problem.

On July 3, 1975, this patient was brought to the Richardson Clinic, after she had been advised by the surgeon that nothing more could be done.

Blood studies were essentially normal. Minerals were balanced following hair analysis. The patient received 9 gms. of Laetrile I.V. for twenty days and then gradually decreased I.V. dosage supplemented by oral medication on the days she did not receive I.V. The headaches were gradually reduced in severity, and in five months they were completely gone.

Bio-assays since starting metabolic therapy have been: (1) 7-3-75, 19.0, (2) 7-25-75, 16.7, (3) 8-22-75, 14.9, (4) 919-75, 14.5, (5) 1-26-76, 14.6, (6)6-9-76, 15.7 1

This woman is alive and well nearly two years following the incomplete removal of a brain tumor. The patient’s father stated in a letter to Dr. Richardson dated January 2, 1977:

At the end of the treatment our doctor [the surgeon] told me that she [the patient] should still try to enjoy herself which she could, for she might be able to live six months, a year or, at most, two years. This meant that orthodox medicine could do no more for her. At the end of our rope we took our daughter to your clinic on July 3, 1975. In October, 1975, she was able to return to work full time and has since been leading a normal life.

My daughter and I are shocked and indignant to learn that Big Brother is prosecuting you for saving lives. We vow that if necessary we’ll fight along side you for our right to live.

SI35C: Cancer of the Brain

Mr. S. was found to have cancer of the brain in December, 1970. He wanted to go on metabolic therapy including Laetrile, but the Richardson Clinic recommended to him that he first have the surgery his doctor had suggested, and then come to the clinic. Surgery was performed January 7, 1971. The patient was told that they could not get all the cancer

and, even with some radiation therapy, he could not possibly live more than six months. The patient came to the Richardson Clinic early in 1971 and has continued faithfully on the metabolic therapy program. Four years later in July, 1975, the Sacramento, California, Sutter Hospital acquired a new scanner. The patient had a brain scan at the time and was told he did not have a trace of cancer. He continues to be in good health and leads a normal, active life.

 

2001 Worldwithoutcancer.org.uk
By Accessing this web site you accept  all its terms and conditions.

©Copyright 2000 - Worldwithoutcancer.org.uk - PO Box 2038 - Leigh-on-Sea - SS9 2ZB - UK
Home | Introduction | Site Map | Success Stories | Research | Products | FAQ | Contact Us | WWC Audio |